Point72 Asset Management
NPCE icon

Point72 Asset Management’s Neuropace NPCE Stock Holding History

Point72 Asset Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Buy
152,025
+127,384
+517% +$1.91M ﹤0.01% 2305
2025
Q4 		$380K Buy
+24,641
New +$330K ﹤0.01% 3375
2025
Q1 		– Sell
-32,943
Closed -$369K – 2369
2024
Q4 		$369K Buy
+32,943
New +$286K ﹤0.01% 1739
2022
Q4 		– Sell
-145,703
Closed -$546K – 1706
2022
Q3 		$546K Sell
145,703
-3,496
-2% -$16.9K ﹤0.01% 1149
2022
Q2 		$739K Sell
149,199
-59,977
-29% -$396K ﹤0.01% 1130
2022
Q1 		$1.72M Buy
209,176
+72,976
+54% +$630K 0.01% 895
2021
Q4 		$1.37M Buy
+136,200
New +$1.77M 0.01% 869

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Point72 Asset Management's NPCE Position: Q1 2026 in Review

Point72 Asset Management increased its Neuropace (NPCE) stake by 517% in Q1 2026, buying an estimated $1.91M and bringing the position to 152,025 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Point72 Asset Management first reported a position in NPCE in Q4 2021 and has held it in 7 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Point72 Asset Management held 152,025 shares of Neuropace worth $2M as of Q1 2026.
  • Point72 Asset Management bought 127,384 Neuropace shares in Q1 2026, an estimated $1.91M.
  • Neuropace made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2305 holding.
  • Point72 Asset Management first reported a position in Neuropace in Q4 2021 and has held it in 7 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.